BRPI0207102A8 - forma cristalina, composição farmacêutica, e, uso de uma forma cristalina. - Google Patents
forma cristalina, composição farmacêutica, e, uso de uma forma cristalina.Info
- Publication number
- BRPI0207102A8 BRPI0207102A8 BRPI0207102A BRPI0207102A BRPI0207102A8 BR PI0207102 A8 BRPI0207102 A8 BR PI0207102A8 BR PI0207102 A BRPI0207102 A BR PI0207102A BR PI0207102 A BRPI0207102 A BR PI0207102A BR PI0207102 A8 BRPI0207102 A8 BR PI0207102A8
- Authority
- BR
- Brazil
- Prior art keywords
- crystalline form
- pharmaceutical composition
- crystals
- preventing
- formula
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000013078 crystal Substances 0.000 abstract 2
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003833 nucleoside derivatives Chemical class 0.000 abstract 1
- 239000002718 pyrimidine nucleoside Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001033128 | 2001-02-09 | ||
| PCT/JP2002/000986 WO2002064609A1 (en) | 2001-02-09 | 2002-02-06 | Crystal of pyrimidine nucleoside derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0207102A8 true BRPI0207102A8 (pt) | 2018-02-27 |
Family
ID=18896929
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0207102A BRPI0207102A8 (pt) | 2001-02-09 | 2002-02-06 | forma cristalina, composição farmacêutica, e, uso de uma forma cristalina. |
| BR0207102-9A BR0207102A (pt) | 2001-02-09 | 2002-02-06 | Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0207102-9A BR0207102A (pt) | 2001-02-09 | 2002-02-06 | Forma cristalina, composição farmacêutica, uso de uma forma cristalina, e, método para a prevenção ou o tratamento de doença |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP1364959B1 (enExample) |
| JP (2) | JP3748536B2 (enExample) |
| KR (1) | KR100679904B1 (enExample) |
| CN (1) | CN100408591C (enExample) |
| AT (1) | ATE361929T1 (enExample) |
| AU (1) | AU2002230164B2 (enExample) |
| BR (2) | BRPI0207102A8 (enExample) |
| CA (1) | CA2437994C (enExample) |
| CY (1) | CY1106685T1 (enExample) |
| CZ (1) | CZ303241B6 (enExample) |
| DE (1) | DE60220024T2 (enExample) |
| DK (1) | DK1364959T3 (enExample) |
| ES (1) | ES2286237T3 (enExample) |
| HU (1) | HU229294B1 (enExample) |
| IL (2) | IL157216A0 (enExample) |
| MX (1) | MXPA03007123A (enExample) |
| NZ (1) | NZ527393A (enExample) |
| PT (1) | PT1364959E (enExample) |
| RU (1) | RU2256666C2 (enExample) |
| WO (1) | WO2002064609A1 (enExample) |
| ZA (1) | ZA200306121B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2077703B1 (en) | 1999-09-02 | 2013-08-21 | Ibiden Co., Ltd. | Printed circuit board and method of manufacturing printed circuit board |
| CN100381026C (zh) | 1999-09-02 | 2008-04-09 | 伊比登株式会社 | 印刷布线板及其制造方法 |
| GB0526419D0 (en) * | 2005-12-23 | 2006-02-08 | Cyclacel Ltd | Formulation |
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP5066737B2 (ja) * | 2007-04-06 | 2012-11-07 | 大鵬薬品工業株式会社 | シチジン誘導体を含有する持続静脈内投与用抗腫瘍剤 |
| US8124593B2 (en) | 2007-11-05 | 2012-02-28 | Cyclacel Limited | Methods of treatment using sapacitabine |
| GB0808357D0 (en) * | 2008-05-08 | 2008-06-18 | Cyclacel Ltd | Process |
| US8530445B2 (en) | 2008-06-09 | 2013-09-10 | Cyclacel Limited | Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as decitabine and procaine |
| WO2012140436A1 (en) | 2011-04-14 | 2012-10-18 | Cyclacel Limited | Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid leukemia |
| ES2880109T3 (es) * | 2012-03-15 | 2021-11-23 | Celgene Car Llc | Formas sólidas de un inhibidor de la cinasa del receptor del factor de crecimiento epidérmico |
| CN107428791B (zh) | 2015-03-09 | 2024-05-28 | 格雷斯公司 | 烟酰胺核苷的结晶形式 |
| WO2019126482A1 (en) | 2017-12-22 | 2019-06-27 | Elysium Health, Inc. | Crystalline forms of nicotinamide riboside chloride |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) * | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| FI105556B (fi) * | 1991-09-30 | 2000-09-15 | Sankyo Co | Menetelmä lääkeaineina käyttökelpoisten pyrimidiiniukleosidijohdannaisten valmistamiseksi, joilla on kasvaimen vastaista vaikutusta |
-
2002
- 2002-02-04 JP JP2002026232A patent/JP3748536B2/ja not_active Expired - Lifetime
- 2002-02-06 AU AU2002230164A patent/AU2002230164B2/en not_active Expired
- 2002-02-06 RU RU2003124648/04A patent/RU2256666C2/ru active
- 2002-02-06 WO PCT/JP2002/000986 patent/WO2002064609A1/ja not_active Ceased
- 2002-02-06 CA CA2437994A patent/CA2437994C/en not_active Expired - Lifetime
- 2002-02-06 HU HU0303159A patent/HU229294B1/hu unknown
- 2002-02-06 IL IL15721602A patent/IL157216A0/xx active IP Right Grant
- 2002-02-06 ES ES02711347T patent/ES2286237T3/es not_active Expired - Lifetime
- 2002-02-06 KR KR1020037010308A patent/KR100679904B1/ko not_active Expired - Lifetime
- 2002-02-06 DK DK02711347T patent/DK1364959T3/da active
- 2002-02-06 NZ NZ527393A patent/NZ527393A/en not_active IP Right Cessation
- 2002-02-06 EP EP02711347A patent/EP1364959B1/en not_active Expired - Lifetime
- 2002-02-06 CN CNB028079337A patent/CN100408591C/zh not_active Expired - Lifetime
- 2002-02-06 BR BRPI0207102A patent/BRPI0207102A8/pt unknown
- 2002-02-06 PT PT02711347T patent/PT1364959E/pt unknown
- 2002-02-06 BR BR0207102-9A patent/BR0207102A/pt not_active Application Discontinuation
- 2002-02-06 CZ CZ20032111A patent/CZ303241B6/cs not_active IP Right Cessation
- 2002-02-06 AT AT02711347T patent/ATE361929T1/de active
- 2002-02-06 DE DE60220024T patent/DE60220024T2/de not_active Expired - Lifetime
- 2002-02-06 MX MXPA03007123A patent/MXPA03007123A/es active IP Right Grant
-
2003
- 2003-08-04 IL IL157216A patent/IL157216A/en unknown
- 2003-08-07 ZA ZA2003/06121A patent/ZA200306121B/en unknown
-
2005
- 2005-08-09 JP JP2005230800A patent/JP4356998B2/ja not_active Expired - Lifetime
-
2007
- 2007-07-02 CY CY20071100860T patent/CY1106685T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0307351A (pt) | Composto, composição farmacêutica, método para tratar uma condição ou estado de doença mediados pela atividade de p38 quinase ou mediados por citocinas produzidas pela atividade de p38 quinase, uso de um composto, e, processo para preparar um composto | |
| BR0212042A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, e, uso de um composto | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| NO20035524D0 (no) | 4'-substituerte nukleosider | |
| BRPI0215312B8 (pt) | composto, uso de um composto, composição farmacêutica, e processo para a preparação de um composto | |
| BR0109703A (pt) | Derivados de piperazina | |
| BRPI0411365A (pt) | derivados de aminopiridina | |
| DE60204452D1 (de) | Pyrazolo[1,5]pyridinderivate | |
| BR9800228A (pt) | Compostos de peridilfurano e piridiltiofeno | |
| TR200201505T2 (tr) | Terapötik maddeler olarak pirazolopirimidinler | |
| NO20006323D0 (no) | Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse | |
| AU2003226572A1 (en) | Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors | |
| BR0316771A (pt) | Compostos para o tratamento ou a prevenção de infecções por flavivirus, uso de um composto e composição farmacêutica | |
| CY1107747T1 (el) | Υποκατεστημενα τετρακυκλικα παραγωγα πυρρολοκινολονης χρησιμα ως αναστολεις της φωσφοδιεστερασης | |
| BR0309343A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| EA200400466A1 (ru) | Производные пиперазина с антагонистической активностью к рецептору ccr1 | |
| BR0309342A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas | |
| GEP20074021B (en) | Hetero biaryl derivatives as matrix metalloproteinase inhibitors | |
| NO20040881L (no) | Orale antidiabetes midler. | |
| WO2004014868A8 (en) | Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors | |
| BRPI0207102A8 (pt) | forma cristalina, composição farmacêutica, e, uso de uma forma cristalina. | |
| NO984470L (no) | Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase | |
| ATE238981T1 (de) | Antitumorwirkstoffe | |
| BR0113590A (pt) | 7-oxo-piridopirimidinas | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. |